The global cognitive behavioral therapy market size is calculated at USD 9.00 billion in 2025 and is forecasted to reach around USD 34.04 billion by 2034, accelerating at a CAGR of 15.96% from 2025 to 2034. The market sizing and forecasts are revenue-based (USD Million/Billion), with 2024 as the base year.
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
3.1. Market Snapshot
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
5.1. COVID-19 Landscape: Cognitive Behavioral Therapy Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
8.1. Cognitive Behavioral Therapy Market, by Type
8.1.1 Cognitive Therapy
8.1.1.1. Market Revenue and Forecast
8.1.2. Dialectical Behavior Therapy
8.1.2.1. Market Revenue and Forecast
8.1.3. Multimodal Therapy
8.1.3.1. Market Revenue and Forecast
8.1.4. Rational Emotive Behavior Therapy (REBT)
8.1.4.1. Market Revenue and Forecast
9.1. Cognitive Behavioral Therapy Market, by Indications
9.1.1. Addiction
9.1.1.1. Market Revenue and Forecast
9.1.2. Anger Issues
9.1.2.1. Market Revenue and Forecast
9.1.3. Depression
9.1.3.1. Market Revenue and Forecast
9.1.4. Anxiety
9.1.4.1. Market Revenue and Forecast
9.1.5. Panic Attacks
9.1.5.1. Market Revenue and Forecast
9.1.6. Phobias
9.1.6.1. Market Revenue and Forecast
10.1. Cognitive Behavioral Therapy Market, by Age Group
10.1.1. Children
10.1.1.1. Market Revenue and Forecast
10.1.2. Adults
10.1.2.1. Market Revenue and Forecast
10.1.3. Geriatric
10.1.3.1. Market Revenue and Forecast
11.1. North America
11.1.1. Market Revenue and Forecast, by Type
11.1.2. Market Revenue and Forecast, by Indications
11.1.3. Market Revenue and Forecast, by Age Group
11.1.4. U.S.
11.1.4.1. Market Revenue and Forecast, by Type
11.1.4.2. Market Revenue and Forecast, by Indications
11.1.4.3. Market Revenue and Forecast, by Age Group
11.1.5. Rest of North America
11.1.5.1. Market Revenue and Forecast, by Type
11.1.5.2. Market Revenue and Forecast, by Indications
11.1.5.3. Market Revenue and Forecast, by Age Group
11.2. Europe
11.2.1. Market Revenue and Forecast, by Type
11.2.2. Market Revenue and Forecast, by Indications
11.2.3. Market Revenue and Forecast, by Age Group
11.2.4. UK
11.2.4.1. Market Revenue and Forecast, by Type
11.2.4.2. Market Revenue and Forecast, by Indications
11.2.4.3. Market Revenue and Forecast, by Age Group
11.2.5. Germany
11.2.5.1. Market Revenue and Forecast, by Type
11.2.5.2. Market Revenue and Forecast, by Indications
11.2.5.3. Market Revenue and Forecast, by Age Group
11.2.6. France
11.2.6.1. Market Revenue and Forecast, by Type
11.2.6.2. Market Revenue and Forecast, by Indications
11.2.6.3. Market Revenue and Forecast, by Age Group
11.2.7. Rest of Europe
11.2.7.1. Market Revenue and Forecast, by Type
11.2.7.2. Market Revenue and Forecast, by Indications
11.2.7.3. Market Revenue and Forecast, by Age Group
11.3. APAC
11.3.1. Market Revenue and Forecast, by Type
11.3.2. Market Revenue and Forecast, by Indications
11.3.3. Market Revenue and Forecast, by Age Group
11.3.4. India
11.3.4.1. Market Revenue and Forecast, by Type
11.3.4.2. Market Revenue and Forecast, by Indications
11.3.4.3. Market Revenue and Forecast, by Age Group
11.3.5. China
11.3.5.1. Market Revenue and Forecast, by Type
11.3.5.2. Market Revenue and Forecast, by Indications
11.3.5.3. Market Revenue and Forecast, by Age Group
11.3.6. Japan
11.3.6.1. Market Revenue and Forecast, by Type
11.3.6.2. Market Revenue and Forecast, by Indications
11.3.6.3. Market Revenue and Forecast, by Age Group
11.3.7. Rest of APAC
11.3.7.1. Market Revenue and Forecast, by Type
11.3.7.2. Market Revenue and Forecast, by Indications
11.3.7.3. Market Revenue and Forecast, by Age Group
11.4. MEA
11.4.1. Market Revenue and Forecast, by Type
11.4.2. Market Revenue and Forecast, by Indications
11.4.3. Market Revenue and Forecast, by Age Group
11.4.4. GCC
11.4.4.1. Market Revenue and Forecast, by Type
11.4.4.2. Market Revenue and Forecast, by Indications
11.4.4.3. Market Revenue and Forecast, by Age Group
11.4.5. North Africa
11.4.5.1. Market Revenue and Forecast, by Type
11.4.5.2. Market Revenue and Forecast, by Indications
11.4.5.3. Market Revenue and Forecast, by Age Group
11.4.6. South Africa
11.4.6.1. Market Revenue and Forecast, by Type
11.4.6.2. Market Revenue and Forecast, by Indications
11.4.6.3. Market Revenue and Forecast, by Age Group
11.4.7. Rest of MEA
11.4.7.1. Market Revenue and Forecast, by Type
11.4.7.2. Market Revenue and Forecast, by Indications
11.4.7.3. Market Revenue and Forecast, by Age Group
11.5. Latin America
11.5.1. Market Revenue and Forecast, by Type
11.5.2. Market Revenue and Forecast, by Indications
11.5.3. Market Revenue and Forecast, by Age Group
11.5.4. Brazil
11.5.4.1. Market Revenue and Forecast, by Type
11.5.4.2. Market Revenue and Forecast, by Indications
11.5.4.3. Market Revenue and Forecast, by Age Group
11.5.5. Rest of LATAM
11.5.5.1. Market Revenue and Forecast, by Type
11.5.5.2. Market Revenue and Forecast, by Indications
11.5.5.3. Market Revenue and Forecast, by Age Group
12.1. Magellan Health Inc.
12.1.1. Company Overview
12.1.2. Product Offerings
12.1.3. Financial Performance
12.1.4. Recent Initiatives
12.2. American Addiction Centres
12.2.1. Company Overview
12.2.2. Product Offerings
12.2.3. Financial Performance
12.2.4. Recent Initiatives
12.3. Peoples Care Holding Inc.
12.3.1. Company Overview
12.3.2. Product Offerings
12.3.3. Financial Performance
12.3.4. Recent Initiatives
12.4. Behavioral Health Group
12.4.1. Company Overview
12.4.2. Product Offerings
12.4.3. Financial Performance
12.4.4. Recent Initiatives
12.5. Acadia HealthCare
12.5.1. Company Overview
12.5.2. Product Offerings
12.5.3. Financial Performance
12.5.4. Recent Initiatives
12.6. Universal Healthcare Services Inc.
12.6.1. Company Overview
12.6.2. Product Offerings
12.6.3. Financial Performance
12.6.4. Recent Initiatives
12.7. Springstone
12.7.1. Company Overview
12.7.2. Product Offerings
12.7.3. Financial Performance
12.7.4. Recent Initiatives
13.1. Primary Research
13.2. Secondary Research
13.3. Assumptions
14.1. About Us
14.2. Glossary of Terms
For questions or customization requests, please reach out to us at sales@precedenceresearch.com
Plan your call and get expert insights!
Schedule a Meeting
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client
Report Description
Get a Sample